EIM
ALXN

ExxonMobil Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

ExxonMobil Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$3.78M Sell
33,937
-1,586
-4% -$190K 0.11% 209
2017
Q4 		$4.25M Sell
35,523
-5,234
-13% -$637K 0.12% 199
2017
Q3 		$5.72M Sell
40,757
-2,358
-5% -$320K 0.14% 172
2017
Q2 		$5.25M Sell
43,115
-6,764
-14% -$787K 0.13% 188
2017
Q1 		$6.05M Sell
49,879
-2,027
-4% -$261K 0.13% 181
2016
Q4 		$6.35M Sell
51,906
-5,353
-9% -$655K 0.14% 175
2016
Q3 		$7.02M Sell
57,259
-729
-1% -$93.8K 0.15% 168
2016
Q2 		$6.77M Buy
57,988
+3,135
+6% +$445K 0.14% 167
2016
Q1 		$7.64M Buy
54,853
+4,348
+9% +$638K 0.17% 140
2015
Q4 		$9.63M Sell
50,505
-1,411
-3% -$246K 0.24% 101
2015
Q3 		$8.12M Buy
51,916
+2,211
+4% +$403K 0.21% 118
2015
Q2 		$8.98M Buy
49,705
+1,092
+2% +$188K 0.22% 112
2015
Q1 		$8.43M Buy
48,613
+1,865
+4% +$338K 0.19% 128
2014
Q4 		$8.65M Sell
46,748
-1,725
-4% -$320K 0.2% 123
2014
Q3 		$8.04M Sell
48,473
-1,851
-4% -$304K 0.19% 132
2014
Q2 		$7.86M Sell
50,324
-1,486
-3% -$235K 0.18% 146
2014
Q1 		$7.88M Buy
51,810
+770
+2% +$122K 0.18% 140
2013
Q4 		$6.79M Sell
51,040
-951
-2% -$114K 0.16% 155
2013
Q3 		$6.04M Sell
51,991
-2,235
-4% -$245K 0.15% 165
2013
Q2 		$5M Buy
+54,226
New +$5.23M 0.13% 195

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ExxonMobil Investment Management's ALXN Position: Q1 2018 in Review

ExxonMobil Investment Management reduced its Alexion Pharmaceuticals (ALXN) stake by 4.5% in Q1 2018, selling an estimated $190K and leaving 33,937 shares worth $3.78M. The position accounts for 0.11% of the portfolio, ranked #209.

ExxonMobil Investment Management first reported a position in ALXN in Q2 2013 and has held it in 20 quarters since. The position peaked at $9.63M in Q4 2015. 597 funds tracked by Wall St. Rank hold ALXN as of Q1 2018.

  • ExxonMobil Investment Management held 33,937 shares of Alexion Pharmaceuticals worth $3.78M as of Q1 2018.
  • ExxonMobil Investment Management sold 1,586 Alexion Pharmaceuticals shares in Q1 2018, an estimated $190K.
  • Alexion Pharmaceuticals made up 0.11% of ExxonMobil Investment Management's portfolio in Q1 2018, its #209 holding.
  • ExxonMobil Investment Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 20 quarters since.
  • ExxonMobil Investment Management's Alexion Pharmaceuticals position peaked at $9.63M in Q4 2015.
  • 597 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2018.

Based on ExxonMobil Investment Management's 13F filing for Q1 2018, filed 12 Apr 2018.